BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by unconsolidated joint ventures, BXP's portfolio totals 53.3 million square feet and 185 properties, including seven properties under construction/redevelopment.

BXP Inc.

In a report released today, Ronald Kamdem from Morgan Stanley reiterated a Hold rating on BXP, with a price target of $60.00. Kamdem covers the Rea...

Morgan Stanley Sticks to Its Hold Rating for BXP (BXP)

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has provided an update. Botanix Pharmaceuticals has announced its participation in the annual Euroz H...

Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference

An announcement from Botanix Pharmaceuticals Limited ( ($AU:BOT) ) is now available. Botanix Pharmaceuticals has updated investors on its proposed ...

Botanix Revises Securities Purchase Plan Timetable and Sets Approval Date

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) has issued an update. Botanix Pharmaceuticals has updated investors on its plans for a new issue of s...

Botanix updates timetable for share purchase plan securities issue

Botanix Pharmaceuticals Limited ( ($AU:BOT) ) just unveiled an announcement. Botanix Pharmaceuticals has opened its security purchase plan as part ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BXP	$52.03	+0.48%	976.26K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BXP	$52.03	+0.5%	976.26K
3
4
5
6

BXP

BXP

Get BXP Inc. Data in Excel

Get BXP Inc. Data in Excel